Irritable bowel syndrome: A comparison of subtypes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 2, 2015, Pages 279-285

  Rey de Castro, Nicolas G ^a   Miller, Vivien ^a   Carruthers, Helen R ^a   Whorwell, Peter J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Irritable bowel syndrome; Psychological factors; Severity; Subtypes

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; AGED; ANXIETY; ARTICLE; CONSTIPATION; COPING BEHAVIOR; DEPRESSION; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SKILL; SOMATIZATION; SYMPTOMATOLOGY; VALIDATION STUDY; VERY ELDERLY; ADAPTIVE BEHAVIOR; ADULT; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; COHORT STUDIES; CONSTIPATION; DEPRESSION; DIARRHEA; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84921484694     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12704     Document Type: Article

References (50)

1. Whorwell PJ. What is irritable bowel syndrome? Therap. Adv. Gastroenterol. 2012; 5: 379-380.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. In: Drossman DA, ed. Rome III: The Functional Gastrointestinal Disorders, 3rd edn. McLean, VA: Degnon Associates, Inc., 2006; 487-555.
3. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 37-40.
4. Maxton DG, Morris JA, Whorwell PJ. Ranking of symptoms by patients with irritable bowel syndrome. BMJ 1989; 299: 1138.
5. Maxton DG, Morris JA, Whorwell PJ. More accurate diagnosis of irritable bowel syndrome by the use of "non-colonic" symptomatology. Gut 1991; 32: 784-786.
6. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada-first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig. Dis. Sci. 2002; 47: 225-235.
7. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90.
8. Drossman DA, Li ZM, Andruzzi E etal. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig. Dis. Sci. 1993; 38: 1569-1580.
9. Talley NJ, Zinsmeister AR, Vandyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-934.
10. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J. Intern. Med. 1994; 236: 23-30.
11. Pan GZ, Lu SC, Ke MY, Han SM, Guo HP, Fang XC. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling. Chin. Med. J. 2000; 113: 35-39.
12. Han SH, Lee OY, Bae SC etal. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J. Gastroenterol. Hepatol. 2006; 21: 1687-1692.
13. Gwee KA, Wee S, Wong ML, Png DJC. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am. J. Gastroenterol. 2004; 99: 924-931.
14. Kwan ACP, Hu WHC, Chan YK, Yeung YW, Lai TST, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J. Gastroenterol. Hepatol. 2002; 17: 1180-1186.
15. Spiller RC. Irritable bowel syndrome: gender, infection, lifestyle or what else? Dig. Dis. 2011; 29: 215-221.
16. Jerndal P, Ringstrom G, Agerforz P etal. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol. Motil. 2010; 22: 646-e179.
17. Thijssen AY, Jonkers D, Leue C etal. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J. Clin. Gastroenterol. 2010; 44: e236-e241.
18. Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig. Dis. Sci. 1980; 25: 404-413.
19. Medeiros MTG, Carvalho AF, Lima JWD, dos Santos AA, de Oliveira RB, Souza M. Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome. J. Nerv. Ment. Dis. 2008; 196: 711-714.
20. Tillisch K, Labus JS, Naliboff BD etal. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am. J. Gastroenterol. 2005; 100: 896-904.
21. Heitkemper M, Cain KC, Shulman R, Burr R, Poppe A, Jarrett M. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern. Dig. Dis. Sci. 2011; 56: 2050-2058.
22. Eriksson EM, Andren KI, Eriksson HT, Kurlberg GK. Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. World J. Gastroenterol. 2008; 14: 4889-4896.
23. Kanazawa M, Palsson OS, Thiwan SIM etal. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am. J. Gastroenterol. 2008; 103: 2550-2561.
24. Prior A, Maxton DG, Whorwell PJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut 1990; 31: 458-462.
25. Mearin F, Balboa A, Badia X etal. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur. J. Gastroenterol. Hepatol. 2003; 15: 165-172.
26. Rome Foundation Inc., Appendix A: Rome III diagnostic criteria for functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Delvaux M, etal., eds. Rome III: The Functional Gastrointestinal Disorders, 3rd edn. McLean, VA: Degnon Associates, 2006; 885-897.
27. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 1997; 32: 920-924.
28. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491.
29. Francis CY, Morris JA, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 1997; 11: 395-402.
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983; 67: 361-370.
31. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am. J. Gastroenterol. 2002; 97: 954-961.
32. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome-the effect of hypnotherapy. Aliment. Pharmacol. Ther. 1996; 10: 91-95.
33. Dunbar G, Stoker M, Hodges T, Beaumont G. The development of SBQOL: a unique scale for measuring quality of life. Br. J. Health Econ. 1992; 2: 65-74.
34. Sadik R, Posserud I, Strid H etal. Colonic transit time influences the abnormal bowel habit, but not other gastrointestinal symptoms, in irritable bowel syndrome. Gastroenterology 2009; 136: A224-A224.
35. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am. J. Gastroenterol. 2007; 102: 2767-2776.
36. Longstreth GF, Woldetsadik G. Irritable bowel-type symptoms in HMO examinees-prevalence, demographics, and clinical correlates. Dig. Dis. Sci. 1993; 38: 1581-1589.
37. Sperber AD, Carmel S, Atzmon Y etal. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am. J. Gastroenterol. 2000; 95: 995-998.
38. Prior A, Whorwell PJ. Gynaecological consultation in patients with the irritable bowel syndrome. Gut 1989; 30: 996-998.
39. Prior A, Wilson K, Whorwell PJ, Faragher EB. Irritable bowel syndrome in the gynecological clinic-survey of 798 new referrals. Dig. Dis. Sci. 1989; 34: 1820-1824.
40. Francis CY, Duffy JN, Whorwell PJ, Morris JA. High prevalence of irritable bowel syndrome in patients attending urological outpatient departments. Dig. Dis. Sci. 1997; 42: 404-407.
41. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673.
42. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14: 125-132.
43. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
44. Park JH, Rhee PL, Kim HS etal. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J. Gastroenterol. Hepatol. 2006; 21: 71-78.
45. Barbara G, Stanghellini V, De Giorgio R etal. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
46. Garnefski N, Grol M, Kraaij V, Hamming JF. Cognitive coping and goal adjustment in people with peripheral arterial disease: relationships with depressive symptoms. Patient Educ. Couns. 2009; 76: 132-137.
47. Wargnies E, Houze L, Vanneste J, Perez T, Wallaert B. Depression, anxiety and coping strategies in adult patients with cystic fibrosis. Rev. Mal. Respir. 2002; 19: 39-43.
48. Lackner JM, Quigley BM, Blanchard EB. Depression and abdominal pain in IBS patients: the mediating role of catastrophizing. Psychosom. Med. 2004; 66: 435-441.
49. Lackner JM, Quigley BM. Pain catastrophizing mediates the relationship between worry and pain suffering in patients with irritable bowel syndrome. Behav. Res. Ther. 2005; 43: 943-957.
50. Herrmann C. International experiences with the hospital anxiety and depression scale-a review of validation data and clinical results. J. Psychosom. Res. 1997; 42: 17-41.